# Liver Resection for Patients With Hepatocellular Carcinoma and Impaired Liver Function

> **NCT06245785** · — · COMPLETED · sponsor: **Tang-Du Hospital** · enrollment: 2200 (actual)

## Conditions studied

- Hepatic Cancer

## Interventions

- **PROCEDURE:** transarterial chemoembolisation

## Key facts

- **NCT ID:** NCT06245785
- **Lead sponsor:** Tang-Du Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2023-04-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 2200 (ACTUAL)
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06245785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06245785, "Liver Resection for Patients With Hepatocellular Carcinoma and Impaired Liver Function". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06245785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*